Published in J Am Chem Soc on April 02, 2014
Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors. Inorg Chem (2015) 0.83
How frequently do clusters occur in hierarchical clustering analysis? A graph theoretical approach to studying ties in proximity. J Cheminform (2016) 0.75
A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase. Antimicrob Agents Chemother (2016) 0.75
Transition Metal Intercalators as Anticancer Agents-Recent Advances. Int J Mol Sci (2016) 0.75
Predicting DNA duplex stability from the base sequence. Proc Natl Acad Sci U S A (1986) 21.73
3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res (2003) 10.63
Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer (2006) 9.15
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem (1985) 8.60
Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (1984) 4.52
Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science (1998) 4.51
A standard reference frame for the description of nucleic acid base-pair geometry. J Mol Biol (2001) 4.29
A model for the mechanism of human topoisomerase I. Science (1998) 4.10
The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci U S A (2002) 3.71
Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res (2004) 3.45
Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB. Nature (2005) 2.91
Antitumour drugs impede DNA uncoiling by topoisomerase I. Nature (2007) 2.77
Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). Proc Natl Acad Sci U S A (1980) 2.67
DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition. Chem Rev (2009) 2.65
Recognition and reaction of metallointercalators with DNA. Chem Rev (1999) 2.59
Drugging topoisomerases: lessons and challenges. ACS Chem Biol (2013) 2.46
Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry (1990) 2.26
Topoisomerase I-mediated DNA damage. Adv Cancer Res (2001) 2.16
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J Med Chem (2005) 2.12
Web 3DNA--a web server for the analysis, reconstruction, and visualization of three-dimensional nucleic-acid structures. Nucleic Acids Res (2009) 2.08
Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet (2001) 2.01
X-ray crystallographic visualization of drug-nucleic acid intercalative binding: structure of an ethidium-dinucleoside monophosphate crystalline complex, Ethidium: 5-iodouridylyl (3'-5') adenosine. Proc Natl Acad Sci U S A (1975) 1.76
Crystal structure of Δ-[Ru(bpy)₂dppz]²⁺ bound to mismatched DNA reveals side-by-side metalloinsertion and intercalation. Nat Chem (2012) 1.59
Insights into finding a mismatch through the structure of a mispaired DNA bound by a rhodium intercalator. Proc Natl Acad Sci U S A (2006) 1.55
Resolving the discrepancies among nucleic acid conformational analyses. J Mol Biol (1999) 1.54
Nature of base stacking: reference quantum-chemical stacking energies in ten unique B-DNA base-pair steps. Chemistry (2006) 1.46
DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol (2007) 1.44
Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res (1989) 1.43
Crystal structures of Λ-[Ru(phen)₂dppz]²⁺ with oligonucleotides containing TA/TA and AT/AT steps show two intercalation modes. Nat Chem (2012) 1.34
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Res (1989) 1.31
Topoisomerase I regulates open chromatin and controls gene expression in vivo. EMBO J (2010) 1.28
Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Res (2003) 1.26
Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity. Biochemistry (1990) 1.20
Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids. J Med Chem (2003) 1.19
DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators. Nucleic Acids Res (1987) 1.17
WEB-THERMODYN: Sequence analysis software for profiling DNA helical stability. Nucleic Acids Res (2003) 1.15
Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. J Med Chem (1999) 1.13
A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry (2010) 1.12
A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity. Proc Natl Acad Sci U S A (2012) 1.07
Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy. Curr Top Med Chem (2003) 1.06
Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors. J Med Chem (2008) 1.05
Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochemistry (2002) 1.04
Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells. Chem Commun (Camb) (2003) 1.00
Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors. Anticancer Agents Med Chem (2008) 0.97
SYBR Green I: fluorescence properties and interaction with DNA. J Fluoresc (2012) 0.93
p53 dependence of topoisomerase I recruitment in vivo. Cancer Res (2000) 0.93
Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochem J (2004) 0.92
The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci (2011) 0.90
Free energy calculations reveal rotating-ratchet mechanism for DNA supercoil relaxation by topoisomerase IB and its inhibition. Biophys J (2010) 0.90
A multiscale dynamic model of DNA supercoil relaxation by topoisomerase IB. Biophys J (2011) 0.88
Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity. J Med Chem (2011) 0.87
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure. Chemistry (2010) 0.83
Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells. Anticancer Res (2003) 0.83
Dual topoisomerase I/II poisons as anticancer drugs. Expert Opin Investig Drugs (1997) 0.83
Synthesis and DNA-Binding Properties of [Ru(NH(3))(4)dppz](2+). Inorg Chem (1998) 0.82
Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor. Int J Antimicrob Agents (2009) 0.82
Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions. Biochemistry (2000) 0.81
Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle. Arch Biochem Biophys (2011) 0.80
Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents. Bioorg Med Chem (2005) 0.80
The influence of ACE ID and ACTN3 R577X polymorphisms on lower-extremity function in older women in response to high-speed power training. BMC Geriatr (2013) 0.79
Gold(III) complexes of pyridyl- and isoquinolylamido ligands: structural, spectroscopic, and biological studies of a new class of dual topoisomerase I and II inhibitors. Inorg Chem (2013) 0.78
[Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors]. Bull Cancer (1996) 0.78
New propylamine oligopyrrole carboxamides linked to a heterocyclic or anthraquinone system: synthesis, DNA binding, topoisomerase I inhibition and cytotoxicity. Eur J Med Chem (2003) 0.78
Dipyrrolylquinoxaline-bridged Schiff bases: a new class of fluorescent sensors for mercury(II). Dalton Trans (2005) 0.77
Mixed ligand cobalt(II) picolinate complexes: synthesis, characterization, DNA binding and photocleavage. Dalton Trans (2010) 0.77
Characterization of novel checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors. Life Sci (2011) 0.77
Analysis of comparative modeling predictions for CASP2 targets 1, 3, 9, and 17. Proteins (1997) 0.76
Induction of mammalian DNA topoisomerase I-mediated DNA cleavage and DNA winding by bulgarein. J Biol Chem (1993) 0.76
A solid phase assay for topoisomerase I interfacial poisons and catalytic inhibitors. Anal Biochem (2011) 0.76
Modelling topoisomerase I inhibition by minor groove binders. Bioorg Med Chem (2011) 0.76
Substituent control of DNA binding modes in a series of chalcogenoxanthylium photosensitizers as determined by isothermal titration calorimetry and topoisomerase I DNA unwinding assay. Bioorg Med Chem (2008) 0.76
Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site. J Mol Biol (2006) 0.75
An overview of second generation biofuel technologies. Bioresour Technol (2009) 2.95
DNA damage, homology-directed repair, and DNA methylation. PLoS Genet (2007) 2.29
Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol (2011) 2.06
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS (2011) 2.04
Recovery from chronic factitious disorder (Munchausen's syndrome): a personal account. Personal Ment Health (2013) 2.04
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study. J Clin Oncol (2012) 1.99
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS (2011) 1.90
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol (2011) 1.77
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One (2012) 1.76
One-dimensional C-H...N hydrogen-bonded polymers in flexible tetrapyridyl systems. Acta Crystallogr C (2007) 1.76
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev (2014) 1.58
Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes Dev (2005) 1.52
Experimental determination of net protein charge, [A]tot, and Ka of nonvolatile buffers in bird plasma. J Appl Physiol (1985) (2006) 1.39
TOF-SIMS analysis of a 576 micropatterned copolymer array to reveal surface moieties that control wettability. Anal Chem (2007) 1.38
Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp (2011) 1.32
Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol Cell Biol (2003) 1.32
Quantification of accuracy and precision of multi-center DTI measurements: a diffusion phantom and human brain study. Neuroimage (2011) 1.30
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol (2010) 1.22
Conformational instability of the cholera toxin A1 polypeptide. J Mol Biol (2007) 1.22
Functional adaptation skills training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. Am J Geriatr Psychiatry (2003) 1.20
Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologies. PLoS One (2013) 1.20
Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. Biomaterials (2010) 1.18
Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. Cancer Res (2003) 1.13
Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant. Pediatr Nephrol (2012) 1.05
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol (2010) 1.05
KARDIA: a Matlab software for the analysis of cardiac interbeat intervals. Comput Methods Programs Biomed (2009) 1.01
Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication. J Mol Biol (2009) 0.99
Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology (2010) 0.99
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent. Drug Metab Dispos (2012) 0.96
DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair. J Biol Chem (2010) 0.95
Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth. Clin Cancer Res (2013) 0.95
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol (2013) 0.95
SUMOylation enhances DNA methyltransferase 1 activity. Biochem J (2009) 0.94
High throughput surface characterization: A review of a new tool for screening prospective biomedical material arrays. J Drug Target (2010) 0.94
Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Pediatr Blood Cancer (2010) 0.94
DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase. J Biol Chem (2004) 0.93
Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunit. Biochemistry (2010) 0.93
Blood donors' helping behavior is driven by warm glow: more evidence for the blood donor benevolence hypothesis. Transfusion (2012) 0.91
Effect of wrinkles on the surface area of graphene: toward the design of nanoelectronics. Nano Lett (2014) 0.91
Exact epidemic models on graphs using graph-automorphism driven lumping. J Math Biol (2010) 0.90
Children and television tipovers: a significant and preventable cause of long-term neurological deficits. J Neurosurg (2005) 0.89
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status. Proc Natl Acad Sci U S A (2002) 0.89
Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neurovirol (2011) 0.88
Lipid rafts alter the stability and activity of the cholera toxin A1 subunit. J Biol Chem (2012) 0.87
Integrated approaches for the public health prioritization of foodborne and zoonotic pathogens. Risk Anal (2009) 0.87
Magnetic resonance spectroscopic studies of alcoholism: from heavy drinking to alcohol dependence and back again. Alcohol Clin Exp Res (2005) 0.87
1,6-Bis[(2,2':6',2''-terpyridin-4'-yl)-oxy]hexa-ne. Acta Crystallogr Sect E Struct Rep Online (2012) 0.87
Targeted DNA methylation by homology-directed repair in mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids Res (2013) 0.86
Syntheses and biological activities of rebeccamycin analogues with uncommon sugars. J Med Chem (2005) 0.86
Avian bornavirus is present in many tissues of psittacine birds with histopathologic evidence of proventricular dilatation disease. J Vet Diagn Invest (2010) 0.86
Structural and functional interactions between the cholera toxin A1 subunit and ERdj3/HEDJ, a chaperone of the endoplasmic reticulum. Infect Immun (2011) 0.86
Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. PLoS One (2012) 0.86
A novel trinuclear zinc(II) cluster with a tetrahedral ZnO4 core. Acta Crystallogr C (2009) 0.86
GADD45α inhibition of DNMT1 dependent DNA methylation during homology directed DNA repair. Nucleic Acids Res (2011) 0.85
Differentiation linked regulation of telomerase activity by Makorin-1. Mol Cell Biochem (2010) 0.85
Structural and Physical Characterization of (Nitrato)iron(III) Porphyrinates [Fe(por)(NO(3))] - Variable Coordination of Nitrate. Polyhedron (2007) 0.85
2-[4-(Methyl-sulfan-yl)phen-yl]naphtho[1,8-de][1,3,2]diaza-borinane. Acta Crystallogr Sect E Struct Rep Online (2011) 0.85
A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data. Regul Toxicol Pharmacol (2006) 0.84
ADP-ribosylation factor 6 acts as an allosteric activator for the folded but not disordered cholera toxin A1 polypeptide. Mol Microbiol (2014) 0.84
Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin. J Biol Chem (2004) 0.84
Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically). Cochrane Database Syst Rev (2011) 0.83
Syntheses and biological activities of disaccharide daunorubicins. J Med Chem (2005) 0.83
Breathing frequency bias in fractal analysis of heart rate variability. Biol Psychol (2009) 0.82
Tactical and operational response to major incidents: feasibility and reliability of skills assessment using novel virtual environments. Resuscitation (2013) 0.81
Multiple sources and routes of information transmission: Implications for epidemic dynamics. Math Biosci (2011) 0.81
Detection of Legionella species in potting mixes using fluorescent in situ hybridisation (FISH). J Microbiol Methods (2011) 0.81
Venusol from Gunnera perpensa: structural and activity studies. Phytochemistry (2004) 0.81
The biomechanical modelling of non-ballistic skin wounding: blunt-force injury. Forensic Sci Med Pathol (2007) 0.81
Electronic tuning of the lability of Pt(II) complexes through pi-acceptor effects. Correlations between thermodynamic, kinetic, and theoretical parameters. Inorg Chem (2003) 0.81
Energy transfer ratio as a metric of right ventricular efficiency in repaired congenital heart disease. Congenit Heart Dis (2013) 0.80
Down modulation of topoisomerase I affects DNA repair efficiency. DNA Repair (Amst) (2003) 0.80
Cu-catalyzed cascades to carbocycles: union of diaryliodonium salts with alkenes or alkynes exploiting remote carbocations. J Am Chem Soc (2014) 0.80
Grape extracts inhibit multiple events in the cell biology of cholera intoxication. PLoS One (2013) 0.80
Assessment for additional spinal trauma in patients with cervical spine injury. Am Surg (2007) 0.80
The use of myocardial and testicular end points as a basis for estimating a proposed tolerable daily intake for sodium monofluoroacetate (1080). Regul Toxicol Pharmacol (2006) 0.79
A Legionnaires' disease outbreak: a water blaster and roof-collected rainwater systems. Water Res (2007) 0.79
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States. Leuk Lymphoma (2014) 0.79
Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity. Protein J (2012) 0.79
Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations. Metabolism (2007) 0.79
A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers. Int J Pharm (2013) 0.78
Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies. Childs Nerv Syst (2006) 0.78
Gold(III) complexes of pyridyl- and isoquinolylamido ligands: structural, spectroscopic, and biological studies of a new class of dual topoisomerase I and II inhibitors. Inorg Chem (2013) 0.78
Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids. PLoS One (2011) 0.78
Comparing face-to-face and online qualitative research with people with multiple sclerosis. Qual Health Res (2014) 0.78
Models to capture the potential for disease transmission in domestic sheep flocks. Prev Vet Med (2012) 0.78
Redox behaviour of cymantrene Fischer carbene complexes in designing organometallic multi-tags. Chemistry (2014) 0.78
Molecular genetic analysis of the hepatocyte growth factor/MET signaling pathway in pediatric medulloblastoma. Genes Chromosomes Cancer (2012) 0.78
New therapeutic perspectives in CCDC6 deficient lung cancer cells. Int J Cancer (2014) 0.78
Clinical nurse specialists' use of evidence in practice: a pilot study. Worldviews Evid Based Nurs (2007) 0.77
Person-centred climate questionnaire (PCQ-S): establishing reliability and cut-off scores in residential aged care. J Nurs Manag (2013) 0.77
(Pyridyl)benzoazole ruthenium(II) and ruthenium(III) complexes: role of heteroatom and ancillary phosphine ligand in the transfer hydrogenation of ketones. Dalton Trans (2013) 0.77
What are the true advantages of a pediatric appendicitis clinical pathway? Am Surg (2006) 0.77
Pyrano-isoflavones with erectile-dysfunction activity from Eriosema kraussianum. Phytochemistry (2002) 0.77
Kinetic and mechanistic study on the reactions of [Pt(bpma)(H2O)]2+ and [Pd(bpma)(H2O)]2+ with some nucleophiles. Crystal structure of [Pd(bpma)(py)](ClO4)2. Dalton Trans (2006) 0.77